USPTO serial 75583446
Reviewed by CopyMark Law Group
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
KATHLEEN MAHER LYNCH
KATHLEEN MAHER LYNCH ELAN PHARMACEUTICAL RESEARCH CORP1300 GOULD DRGAINESVILLE, GA 30504UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Oral pharmaceutical preparations used for the buccal delivery of drugs, namely, disintregratable mouth soluble tablets in the nature of antacids, antispasmodics and anti-ulcerants, anti-diarrhoeals, colorectal agents, cardiac drugs, CNS stimulants, analgesics, antipyretics and anti-inflammatory agents, muscle relaxants, hormonal, enzymal and steroidal preparations, drugs affecting bone metabolism, drugs affecting the genito-urinary system, diuretics and anti-diuretics, anti-infectives, anti-virals and immunological agents, electrolytes, vitamins and anabolic agents, bronchodilators, anti-asthmatics, expectorants, anti-tussives, decongestants, mucolytics and respiratory stimulants, oropharyngeal, aural and ocular preparations, anti-allergic drugs, hyposensitizing preparations, local and general anesthetics, oral and transdermal contraceptives, medical diagnostic reagents, anti-sense, oglionucleatides, mucosal vaccines, gene-based medicines, permeability and enhancing agents; and for the treatment of disorders of the central nervous system, dermatological disorders, antineoplastic pharmaceutical preparations for inhibiting or preventing the growth and spread of neoplasms or malignant cells | SECTION 8 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 16, 2009 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 8, 2008 | CFIT | CASE FILE IN TICRS | — |
| Sep 3, 2002 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 11, 2002 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 22, 2002 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 2, 2001 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 16, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 20, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 7, 2001 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 30, 2000 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 29, 2000 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Mar 13, 2000 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Feb 25, 2000 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Dec 6, 1999 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 4, 1999 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 26, 1999 | DOCK | ASSIGNED TO EXAMINER | — |